GlassScriptPhysician profile
Jennifer A Jonkers
NPI 1548339989
$8,014.91
in general payments reported to CMS, 2019-2025
45 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 90% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $850 · 2020: $880 · 2021: $1,171 · 2022: $1,519 · 2023: $1,471 · 2024: $980 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,595.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,154.65 | 2019-2025 | Farxiga, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $946.32 | 2019-2025 | Trelegy Ellipta, Shingrix, Nucala |
| Novo Nordisk INC | $841.49 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $598.39 | 2019-2024 | Spravato, Xarelto |
| Amgen INC. | $580.84 | 2019-2025 | Repatha, Otezla, Otezla |
| Abbott Laboratories | $537.48 | 2021-2025 | Freestyle Libre 3 |
| Pfizer INC. | $467.33 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $390.69 | 2020-2025 | Dupixent |
| Lilly USA, LLC | $314.94 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $314.88 | 2019-2025 | Ofev |
| Novartis Pharmaceuticals Corporation | $258.94 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.54 | 2021-2023 | |
| Abbvie INC. | $140.14 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $108.91 | 2022-2025 | Eliquis, Camzyos |
| Mylan Specialty L.P. | $106.84 | 2023-2024 | Yupelri |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Jonkers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.